Gene Editing Market Analysis, Share, Growth & Forecast [2031]
Gene Editing Market Analysis, Share, Growth & Forecast [2031]
Segments - Global Gene Editing Market by Technology (CRISPR, TALEN, and ZFN), End-users (Pharmaceutical, Biotechnology, and Academia), Applications (Cell Line Engineering, Genetic Engineering, and Diagnostics), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Forecasts, 2021-2028
Upcoming
| Report ID :HC-3943
| 4.8 Rating
| 61 Reviews
| 165 Pages
| Format :
Report Description
The global gene editing market is expected to grow at a substantial CAGR during the forecast period of 2021-2028. Current developments in gene editing processes have helped the market to reach new heights in the gene editing abilities due to wide advancement in technology for the modification of gene sequences and arrangements of model organisms and cell types. Gene engineering, widely adopted by several research organizations, are increasingly used by government-based research centres and academia and it has now become a great tool for transformative diagnostic and most importantly for oncology studies. The wide application of the process among academics to clinical and diagnostic laboratories is basically influenced by swift changes in gene editing technology. The COVID-19 pandemic has caused problems for many biotechnological and pharmaceutical companies and other players associated with the genomic market as there was radical shift to invest in vaccine research and development of the coronavirus.
Market Trends, Drivers, Restraints, and Opportunities:
- Significant investment in the field of genomics from key players with setting objectives for the development of new technology in gene editing process is expected to boost the market growth during the forecast period.
- Wide involvement of government funding to enable academic and government institutes to carry out in-depth research related to gene editing as well as engineering is a key driver of the market expansion.
- Growth in the personalized medicine market and wide occurrence of gene disorder diseases are expected to offer immense opportunities to players in the gene editing market.
- High cost of gene editing instruments is a major challenge projected to hamper the market growth during the forecast period. The devices equipped with advanced features and high functionalities are normally priced at a range of USD 10-20 million.
Scope of the report:
The report on the global gene editing market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
|
Attributes |
Details |
|
Report Title |
Gene Editing Market – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2020 |
|
Historic Data |
2018 & 2019 |
|
Forecast Period |
2021–2028 |
|
Segmentation |
Technology (CRISPR, TALEN, and ZFN), End-users (Pharmaceutical, Biotechnology, and Academia), Applications (Cell Line Engineering, Genetic Engineering, and Diagnostics) |
|
Regional Scope |
Asia Pacific, North America, Europe, Latin America, and Middle East & Africa |
|
Report Coverage |
Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast |
|
Key Players Covered |
Thermo Fisher Scientific Inc.; Merck KGaA; and GenScript |
Gene Editing Market Segment Insights:
CRISPR segment is projected to account for a significant market share
In terms of the technology, the market is divided into CRISPR, TALEN, and ZFN. The CRISPR segment dominated the market in 2020 and is projected to account for a significant market share during the projected period. The growth of the segment is attributed to wide adoption of the technique as it offers certain practical benefits the genome modification and sequencing. Moreover, wide advantage in illness recovery due to high adoption of a guide RNA-specific, effective gene transformation, and favourable regulation are key aspects, which help to rise in the acceptance of CRISPR technology across hospitals and clinics. Moreover, the clinical uses of CRISPR are widely accepted worldwide due to growing number of gene-editing trails and rapid development of treatment techniques for various diseases such as AIDS, cancer, and genetic diseases. Moreover, this technology is further applied in various animal breeding and agriculture applications.
Pharmaceutical and biotechnological segments are likely to dominate the market
On the basis of end-users, the global gene editing market is segmented into pharmaceutical, biotechnology, and academia. The biotechnology and pharmaceutical segments are likely to dominate the market during the projected period owing to the growing number of research activities for novel therapeutic development for various applications. Moreover, global pharmaceutical companies are collaborating with newly emerging companies to develop novel technologies. However, the academia segment is projected to constitute a key market share in the coming years owing to wide government funding on research collaborated with academic institutes to expedite new genome study and experiments. The segment growth is further attributed to the increasing the number of gene-editing technologies in University-level projects along with active engagement of research institutes.
Cell line engineering segment is anticipated to expand at a robust growth rate
Based on applications, the market is segmented into cell line engineering, genetic engineering, and diagnostics. The cell line engineering segment is anticipated to expand at a robust growth rate in the coming years as the developments in gene editing systems have revolutionized the genetic engineering space, with cell line engineering at the forefront. The usage of CRISPR gene editing in human-induced pluripotent stem cells (hiPSCs) related programs has important effects in stem cell research for the treatment of various diseases. The CRISPR technology is widely being applied to enhance the productivity of CHO cell lines, which are prominently used in the production of large molecule therapeutics.
North America is projected to represent a high market share
In terms of regions, the global gene editing market is categorized as Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America accounted for a dominant share of the market, followed by Europe in 2020. The market of North America is projected to represent a high market share during the forecast period owing to the rapid development of gene therapy, increased use of GM crops, and rise in the availability of research grants and funding especially in the US. The market in Canada is expected to register substantial growth in the coming years owing to various government initiatives and the intensification of genomics R&D (through GAPP) in the country.
Segments
Segments covered in the report:
By Technology
- CRISPR
- TALEN
- ZFN
- Pharmaceutical
- Biotechnology
- Academia
- Cell Line Engineering
- Genetic Engineering
- Diagnostics
- North America
- Europe
- Latin America
- Asia Pacific
- Thermo Fisher Scientific Inc.
- Merck KGaA
- GenScript
Competitive Landscape
Some of the key players in the market are Thermo Fisher Scientific Inc.; Merck KGaA; and GenScript. These players are actively engaged in various business development strategies including mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Gene Editing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Gene Editing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Gene Editing Market - Supply Chain
4.5. Global Gene Editing Market Forecast
4.5.1. Gene Editing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Gene Editing Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Gene Editing Market Absolute $ Opportunity
5. Global Gene Editing Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Gene Editing Market Size and Volume Forecast by Applications
5.3.1. Cell Line Engineering
5.3.2. Genetic Engineering
5.3.3. Diagnostics
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Gene Editing Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Gene Editing Market Size and Volume Forecast by End Users
6.3.1. Pharmaceutical
6.3.2. Biotechnology
6.3.3. Academia
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Gene Editing Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Gene Editing Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Gene Editing Demand Share Forecast, 2019-2026
8. North America Gene Editing Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Gene Editing Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Gene Editing Market Size and Volume Forecast by Applications
8.4.1. Cell Line Engineering
8.4.2. Genetic Engineering
8.4.3. Diagnostics
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America Gene Editing Market Size and Volume Forecast by End Users
8.7.1. Pharmaceutical
8.7.2. Biotechnology
8.7.3. Academia
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Gene Editing Demand Share Forecast, 2019-2026
9. Latin America Gene Editing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Gene Editing Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Gene Editing Market Size and Volume Forecast by Applications
9.4.1. Cell Line Engineering
9.4.2. Genetic Engineering
9.4.3. Diagnostics
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America Gene Editing Market Size and Volume Forecast by End Users
9.7.1. Pharmaceutical
9.7.2. Biotechnology
9.7.3. Academia
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Gene Editing Demand Share Forecast, 2019-2026
10. Europe Gene Editing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Gene Editing Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Gene Editing Market Size and Volume Forecast by Applications
10.4.1. Cell Line Engineering
10.4.2. Genetic Engineering
10.4.3. Diagnostics
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe Gene Editing Market Size and Volume Forecast by End Users
10.7.1. Pharmaceutical
10.7.2. Biotechnology
10.7.3. Academia
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Gene Editing Demand Share Forecast, 2019-2026
11. Asia Pacific Gene Editing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Gene Editing Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Gene Editing Market Size and Volume Forecast by Applications
11.4.1. Cell Line Engineering
11.4.2. Genetic Engineering
11.4.3. Diagnostics
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific Gene Editing Market Size and Volume Forecast by End Users
11.7.1. Pharmaceutical
11.7.2. Biotechnology
11.7.3. Academia
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Gene Editing Demand Share Forecast, 2019-2026
12. Middle East & Africa Gene Editing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Gene Editing Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Gene Editing Market Size and Volume Forecast by Applications
12.4.1. Cell Line Engineering
12.4.2. Genetic Engineering
12.4.3. Diagnostics
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa Gene Editing Market Size and Volume Forecast by End Users
12.7.1. Pharmaceutical
12.7.2. Biotechnology
12.7.3. Academia
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Gene Editing Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Gene Editing Market: Market Share Analysis
13.2. Gene Editing Distributors and Customers
13.3. Gene Editing Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Thermo Fisher Scientific Inc.
13.4.2. Merck KGaA
13.4.3. GenScript
Methodology
Related Reports
Some other reports from this category!
Our Clients
